Geneoscopy Prepares Launch of FDA-approved At-home RNA Colorectal Cancer Screening Test
Geneoscopy is poised to commercialize Colosense, its noninvasive, at-home multitarget stool RNA test for colorectal cancer screening. In 2025, the St. Louis, MO-based life sciences company focused on developing diagnostic tests for gastrointestinal health, …